Renaissance Technologies (RenTech)'s NMRA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.39 M shares of Neumora Therapeutics, Inc. (NMRA) worth $2.71 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in NMRA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 1.26 M shares. Largest reduction occurred in Q3 2025, reducing 270,551 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Neumora Therapeutics (NMRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Neumora Therapeutics (NMRA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -56,904 | Reduce 3.94% | 1.39 M | $1.95 |
| Q4 2025 | +281,926 | Add 24.22% | 1.45 M | $1.79 |
| Q3 2025 | -270,551 | Reduce 18.86% | 1.16 M | $1.82 |
| Q2 2025 | +174,997 | Add 13.89% | 1.43 M | $0.73 |
| Q1 2025 | +1.26 M | New Buy | 1.26 M | $1.00 |
| Q2 2024 | -138,900 | Sold Out | 0 | $0.00 |
| Q1 2024 | +125,300 | Add 921.32% | 138,900 | $13.75 |
| Q4 2023 | +13,600 | New Buy | 13,600 | $17.06 |
Renaissance Technologies (RenTech)'s Neumora Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Neumora Therapeutics, Inc. (NMRA) in Q4 2023, acquiring 13,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Neumora Therapeutics, Inc. (NMRA) for 8 quarters since Q4 2023.
Renaissance Technologies (RenTech)'s largest addition to Neumora Therapeutics, Inc. (NMRA) was in Q1 2025, adding 1,259,530 shares worth $1.26 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,388,998 shares of Neumora Therapeutics, Inc. (NMRA), valued at approximately $2.71 M.
As of the Q1 2026 filing, Neumora Therapeutics, Inc. (NMRA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Neumora Therapeutics, Inc. (NMRA) was 1,445,902 shares, as reported at the end of Q4 2025.